Galera Therapeutics, Inc. OQB:GRTX
Institutional holders, quarter-over-quarter share deltas, and new and closed positions disclosed in Form 13F. Period 2024-12-31 · prior 2024-09-30.
New Positions(2)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| BIT Capital GmbH | 320,000 | +320,000 | $1.0M | +$1.0M | — |
| JPMORGAN CHASE & CO | 48 | +48 | $6 | +$6 | — |
Sold Out(3)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| Jump Financial, LLC | 0 | -59,720 | $0 | -$186.3K | — |
| Royal Bank of Canada | 0 | -35,403 | $0 | -$5.0K | — |
| MORGAN STANLEY | 0 | -2,831 | $0 | -$396 | — |
Top Holders by reported value
Ranked by the dollar value reported on the latest Form 13F. Share counts reflect long positions as of 2024-12-31.
| Manager | Shares | $ Value | Δ Shares | QoQ % |
|---|---|---|---|---|
| BIT Capital GmbH | 320,000 | $1.0M | +320,000 | — |
| JPMORGAN CHASE & CO | 48 | $6 | +48 | — |
New & Closed Positions this quarter
- Jump Financial, LLC$186.3K
- Royal Bank of Canada$5.0K
- MORGAN STANLEY$396
Methodology
Form 13F is the SEC's quarterly disclosure for institutional investment managers exercising discretion over $100 million or more in qualifying U.S. equity securities. Managers must file within 45 days of each calendar quarter end, which is why holdings shown here reflect a snapshot at the period date — not real-time positioning.
Quarter-over-quarter deltas compare each manager's most recently reported share count for GRTX against its prior-quarter count. New positions are entries where the prior count was zero; closed positions are entries where the current count is zero. Amendments (13F-HR/A) replace prior filings for the same period.
Source: SEC EDGAR Form 13F (XML information tables). Dollar values are as reported by the manager and may use mid-quarter pricing conventions. CUSIP-to-ticker resolution is best-effort.